PRO1107 in Patients With Advanced Solid Tumors
Condition(s):Endometrial Cancer; Ovarian Cancer; Triple Negative Breast Cancer; GastroEsophageal Cancer; Non-small Cell Lung Cancer; Urothelial CarcinomaLast Updated:February 6, 2024Recruiting
Hide Studies Not Open or Pending
Condition(s):Endometrial Cancer; Ovarian Cancer; Triple Negative Breast Cancer; GastroEsophageal Cancer; Non-small Cell Lung Cancer; Urothelial CarcinomaLast Updated:February 6, 2024Recruiting
Condition(s):Malignant Tumor; Advanced Solid Tumor; Glioblastoma Multiforme; Metastatic CancerLast Updated:August 10, 2022Recruiting
Condition(s):Cancer; Melanoma; Breast Cancer; Head and Neck Cancer; Lymphoma; Triple-Negative Breast CancerLast Updated:October 3, 2018Completed
Condition(s):Colorectal Cancer; Triple Negative Breast Cancer; Sarcoma; Nasopharyngeal Carcinoma; Prostate Cancer; Gastric CancerLast Updated:September 27, 2019Unknown status
Condition(s):Breast CancerLast Updated:February 21, 2023Recruiting
Condition(s):Metastatic Breast CancerLast Updated:February 8, 2023Completed
Condition(s):Breast Cancer Female; Breast CancerLast Updated:November 7, 2023Recruiting
Condition(s):Tubular Breast Cancer Stage II; Mucinous Breast Cancer Stage II; Breast Cancer Female NOS; Invasive Ductal Breast Cancer; Tubular Breast Cancer Stage III; HER-2 Positive Breast Cancer; Inflammatory Breast Cancer Stage IV; Inflammatory Breast CancerLast Updated:February 15, 2016Completed
Condition(s):Advanced Solid Tumors (Part A/B/C/D); Non-small Cell Lung Cancer (Part E); Melanoma (Part E); Squamous Cell Cancer of the Head and Neck (Part E); Triple Negative Breast Cancer (Part F); Adrenocortical Carcinoma (Part G); Mesothelioma (Part G); High-circulating Myeloid-derived Suppressor Cells (Part H)Last Updated:April 4, 2022Active, not recruiting
Condition(s):Breast CancerLast Updated:August 31, 2018Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.